FDA has accepted and granted Priority Review to the biologics license application for ifinatamab deruxtecan in adults with ...
GSK has reported encouraging early clinical data from the global phase I BEHOLD-1 trial of mocertatug rezetecan, a ...
Researchers at MD Anderson identified DPY30 as a key biomarker and epigenetic regulator that enables pancreatic tumors to ...
A new study led by UCL researchers suggests that making cancer cells more visible to the immune system could broaden the ...
Researchers from MD Anderson identified DHODH as a key metabolic driver of radiotherapy resistance in lung cancer. Radiation ...
Neladalkib has been submitted for FDA review in TKI pre-treated advanced ALK-positive NSCLC, based on data from the global ...
Researchers developed MIL33B, a high-affinity antibody that selectively targets the tumor-associated 4Ig-B7-H3 isoform while ...
CART-007, an off-the-shelf CAR-T therapy for relapsed or refractory T-ALL and T-LL, two aggressive T-cell cancers with poor ...
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results